Wed, Jul 30, 2014, 7:44 PM EDT - U.S. Markets closed

Recent

% | $
Click the to save as a favorite.

Momenta Pharmaceuticals Inc. Message Board

  • ubahedge ubahedge Feb 9, 2012 1:14 PM Flag

    No one should be surprised!

    Change in Royalty payments was expected and more Lovenox generics are likely at some point. Don't be surprised! This stock is not about Lovenox anymore! It's about a strong B/S with boatloads of cash, royalty payments that cover R&D, and THE BEST technology platform for biosimilars. Copaxone approval alone will double the stock! Of course, TEVA will try to stop the product launch, but ultimately that won't work. Then we have the rest of the pipeline and a HUGE addressable market for biosimilars! This could be a $100 stock in 5 years!

 
MNTA
11.08+0.12(+1.09%)Jul 30 3:59 PMEDT

Trending Tickers

i
Trending Tickers features significant U.S. stocks showing the most dramatic increase in user interest in Yahoo Finance in the previous hour over historic norms. The list is limited to those equities which trade at least 100,000 shares on an average day and have a market cap of more than $300 million.